Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FCGRT | P55899 | 11/20 | 0.52 |
| ▸ | APLNR | P35414 | 4/20 | 0.50 |
| ▸ | GNRHR | P30968 | 1/20 | 0.50 |
| ▸ | NMUR2 | Q9GZQ4 | 1/20 | 0.50 |
| ▸ | NMUR1 | Q9HB89 | 1/20 | 0.50 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.50 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30729467 | 0.77 | AGTR2 (0.68) | FCGRTAPLNRAGTR1AGTR2 | |
| SCHEMBL30514724 | 0.73 | IL23R (0.59) | FCGRTAGTR1AGTR2 | |
| SCHEMBL29519149 | 0.73 | REN (0.62) | APLNRNMUR2NMUR1AGTR1AGTR2 | |
| SCHEMBL29635962 | 0.72 | KISS1R (0.52) | APLNR | |
| SCHEMBL29431992 | 0.70 | NPY1R (0.60) | NMUR2NMUR1 | |
| Angiotensin Amide SCHEMBL27944927 | 0.70 | AGTR2 (0.88) | AGTR1AGTR2 | |
| SCHEMBL29683615 | 0.70 | OPRK1 (0.53) | NMUR2NMUR1 | |
| SCHEMBL28133071 | 0.70 | APLNR (0.92) | APLNRGNRHR | |
| Angiotensin Amide SCHEMBL21811345 | 0.70 | AGTR2 (0.86) | AGTR1AGTR2 | |
| Acetic Acid SCHEMBL19712187 | 0.70 | PTGS1 (0.88) | APLNRGNRHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4129318-A1 | PROTEIN-BASED PHARMACEUTICAL COMPOSITION WITH NEUROPROTECTIVE, IMMUNOMODULATING, ANTI-INFLAMMATORY AND ANTIMICROBIAL ACTIVITY | Centro Nacional de Biopreparados (CU) | 2023-02-08 | — | — | EP | claimed |
| CN-115209908-A | Protein-based pharmaceutical compositions with neuroprotective, immunomodulatory, anti-inflammatory and antimicrobial activities | 国家生物医学中心 | 2022-10-18 | — | — | CN | claimed |
| US-20230405142-A1 | PROTEIN-TEMPLATED SELF-ASSEMBLY OF A COVALENT POLYMER NETWORK FOR INTRACELLULAR TRAFFICKING AND TRACELESS RELEASE | UNIV MASSACHUSETTS (US) | 2023-12-21 | — | — | US | disclosed |
| US-11672867-B2 | Protein-templated self-assembly of a covalent polymer network for intracellular trafficking and traceless release | UNIVERSITY OF MASSACHUSETTS (US) | 2023-06-13 | — | — | US | disclosed |
| EP-4129318-A1 | PROTEIN-BASED PHARMACEUTICAL COMPOSITION WITH NEUROPROTECTIVE, IMMUNOMODULATING, ANTI-INFLAMMATORY AND ANTIMICROBIAL ACTIVITY | Centro Nacional de Biopreparados (CU) | 2023-02-08 | — | — | EP | disclosed |
| US-11567084-B2 | Microwave enhanced enzymatic reactor for proteomics by mass spectrometry | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2023-01-31 | — | — | US | disclosed |
| CN-115209908-A | Protein-based pharmaceutical compositions with neuroprotective, immunomodulatory, anti-inflammatory and antimicrobial activities | 国家生物医学中心 | 2022-10-18 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11672867-B2 | Protein-templated self-assembly of a covalent polymer network for intracellular trafficking and traceless release | CCL2, ACTB, TIA1 | FCGRT 79/4885APLNR 67/4885GNRHR 2240/4885 |
| US-20230405142-A1 | PROTEIN-TEMPLATED SELF-ASSEMBLY OF A COVALENT POLYMER NETWORK FOR INTRACELLULAR TRAFFICKING AND TRACELESS RELEASE | CCL2, ACTB, TIA1 | FCGRT 79/4885APLNR 67/4885GNRHR 2240/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.